Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy Publisher



Asgarbeik S1 ; Amoli MM2 ; Enayati S3 ; Bandarian F4 ; Nasliesfahani E5, 7 ; Forouzanfar K6 ; Razi F5, 7 ; Angaji SA1
Authors

Source: International Journal of Molecular and Cellular Medicine Published:2019


Abstract

Nephropathy is a common diabetes complication. ERRFI1 gene which participates in various cellular pathways has been proposed as a candidate gene in diabetic nephropathy. This study aimed to investigate the role of +808T/G polymorphism (rs377349) in ERRFI1 gene in diabetic nephropathy. In this case-control study, patients including diabetes with nephropathy (DN=104), type 2 diabetes without nephropathy (DM=100), and healthy controls (HC=106) were included. DNA was extracted from blood, and genotyping of the +808T/G polymorphism was carried out using PCR-RFLP technique. The differences for genotype and allele frequencies for +808T/G polymorphism in ERRFI1 gene between DN vs. HC and DN+DM vs. HC were significant (P<0.05) while no significant difference between DN and DM was observed. The allele frequencies were significantly different in DN vs. HC and DN+DM vs. HC in males but not in females. G allele of +808T/G polymorphism in ERRFI1 gene has no significant role in development and progression of diabetic nephropathy in diabetes patients while it is a risk allele for developing diabetes in Iranian population. © 2019, Babol University of Medical Sciences.
Other Related Docs
5. Increased Levels of Soluble Tnf-R1 and Serum Amyloid a in Patients With Diabetic Nephropathy, International Journal of Diabetes in Developing Countries (2026)
14. Association of Serum Uric Acid With Nephropathy in Iranian Type 2 Diabetic Patients, Journal of Diabetes and Metabolic Disorders (2018)
18. Iran Diabetes Research Roadmap (Idrr) Study: An Overview, Iranian Journal of Public Health (2017)
19. Mapping Research in Diabetes Complications; a Scoping Review, Journal of Diabetes and Metabolic Disorders (2022)